| Nanosecond electric pulses rapidly enhance the inactivation of Gram-negative bacteria using Gram-positive antibiotics RA Vadlamani, A Dhanabal, DA Detwiler, R Pal, J McCarthy, MN Seleem, ... Applied microbiology and biotechnology 104, 2217-2227, 2020 | 20 | 2020 |
| β, γ-Diaryl α-methylene-γ-butyrolactones as potent antibacterials against methicillin-resistant Staphylococcus aureus HJ Hamann, NS Abutaleb, R Pal, MN Seleem, PV Ramachandran Bioorganic Chemistry 104, 104183, 2020 | 13 | 2020 |
| Screening of Natural Products and Approved Oncology Drug Libraries for Activity against Clostridioides difficile R Pal, MN Seleem Scientific Reports 10 (1), 5966, 2020 | 13 | 2020 |
| Probiotics: insights and new opportunities for Clostridioides difficile intervention R Pal, AIM Athamneh, R Deshpande, JAR Ramirez, KT Adu, ... Critical reviews in microbiology 49 (3), 414-434, 2023 | 10 | 2023 |
| High-throughput screening identifies a novel natural product-inspired scaffold capable of inhibiting Clostridioides difficile in vitro R Pal, M Dai, MN Seleem Scientific reports 11 (1), 10913, 2021 | 7 | 2021 |
| Discovery of a novel natural product inhibitor of Clostridioides difficile with potent activity in vitro and in vivo R Pal, MN Seleem Plos one 17 (8), e0267859, 2022 | 5 | 2022 |
| Discovery of 1, 2-diaryl-3-oxopyrazolidin-4-carboxamides as a new class of MurA enzyme inhibitors and characterization of their antibacterial activity RA Wagdy, NS Abutaleb, RK Fathalla, Y Elgammal, S Weck, R Pal, ... European Journal of Medicinal Chemistry 261, 115789, 2023 | | 2023 |
| Identification of N-(5-nitrothiazol-2-yl)-3-oxopyrazolidine-4-carboxamide derivative as a potent inhibitor of Clostridioides difficile R Wagdy, N Abutaleb, Y El-Gammal, R Pal, A Abadi, M Seleem, M Engel, ... MDPI, 2023 | | 2023 |
| Antisense inhibition of RNA polymerase α subunit of Clostridioides difficile R Pal, MN Seleem Microbiology Spectrum 11 (5), e01755-23, 2023 | | 2023 |
| Identification of N-(5-Nitrothiazol-2-yl)-3-oxopyrazolidine-4-carboxamide Derivative as a Potent Inhibitor of Clostridioides difficile. 2023, 14, x RA Wagdy, NS Abutaleb, Y Elgammal, R Pal, AH Abadi, MN Seleem, ... | | 2023 |
| Investigating novel treatment approaches to combat Clostridioides difficile R Pal Virginia Polytechnic Institute and State University, 2022 | | 2022 |
